Enhua Wang

8.2k citations
317 papers · 6.6k indexed · 1 hit paper · h-index 37

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
  • Oncology top 1%
    • Cancer-related Molecular Pathways

Papers in

    • Cancer-related Molecular Pathways 28
    • Cancer-related gene regulation 79
    • Wnt/β-catenin signaling in development and cancer 78
    • RNA modifications and cancer 32
    • Epigenetics and DNA Methylation 32
    • RNA Research and Splicing 22

Enhua Wang

313 papers receiving 6.5k citations

Hit Papers

PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma 2016 · 438 citations
4382016202620192022100200300400

Peers

Enhua Wang
Comparison fields: 5 of 130
  • Cancer Research 1.3k
  • Oncology 1.8k
  • Molecular Biology 4.4k
  • Cell Biology 966
  • Immunology 703
Replace Toshiyuki Ishiwata with:
Toshiyuki Ishiwata Japan
Shiaw‐Yih Lin United States
Giuseppe Viglietto Italy
Jan Köster Netherlands
Carol J. Thiele United States
Katsuhiro Uzawa Japan
Martín E. Fernández-Zapico United States
Roberta Maestro Italy
Francesc Viñals Spain
Rachel A. Ridgway United Kingdom
Enhua Wang relative to Toshiyuki Ishiwata Japan Toshiyuki Ishiwata's profile →
Citations per field
00.5×1.5×2.0×
Toshiyuki Ishiwata · 1×
Citations per year

Countries citing papers authored by Enhua Wang

Since Specialization
Citations

This map shows the geographic impact of Enhua Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enhua Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enhua Wang more than expected).

Fields of papers citing papers by Enhua Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enhua Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enhua Wang. The network helps show where Enhua Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Enhua Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Enhua Wang Line = papers co-authored together Enhua Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20241
4 202012
5 20191
6 201716
7 20162
8 201555
9 201530
10 201440
11 201332
12 20126
13 20112
14 20112
15 2010285
16 201036
17 20083
18 200627
19 20032
20
Effect of PEG on germination and active oxygen metabolism in wildrye (Leymus chinensis) seeds
200226

About Enhua Wang

Enhua Wang is a scholar working on Oncology, Molecular Biology, Cell Biology, Cancer Research and Immunology and Allergy, having authored 317 papers that have together received 6.6k indexed citations. Recurring topics across this work include Cancer-related gene regulation (79 papers), Wnt/β-catenin signaling in development and cancer (78 papers), RNA modifications and cancer (32 papers), Epigenetics and DNA Methylation (32 papers), Cancer-related Molecular Pathways (28 papers), Lung Cancer Treatments and Mutations (23 papers), RNA Research and Splicing (22 papers) and Hippo pathway signaling and YAP/TAZ (20 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.8k citations), Molecular Biology (4.4k citations), Cell Biology (966 citations) and Immunology (703 citations). Enhua Wang has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Xueshan Qiu, Qianze Dong, Yuan Miao, Qingchang Li, Xuyong Lin, Hong‐Tao Xu, Liang Wang, Xiupeng Zhang, Shun‐Dong Dai and Guiyang Jiang. Their work appears in journals such as Tumor Biology, PLoS ONE, Diagnostic Pathology, Molecular Carcinogenesis and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026